Muffly, L., Abadir, E., Geyer, M., Cassaday, R., Roloff, G., Sica, R. A., Stock, W., McNulty, E., Rosario, M. D., Shi, X., Liu, Y., Yu, Y., Zhou, Y., Gao, M., Ge, W., Han, L., Ni, Y., Ren, J., Davidson-Moncada, J., Jain, N. (2025). A single-arm, open-label, multi-center, phase 1b/2 Study to evaluate the safety, efficacy, and cellular pharmacokinetic profile of CTD402 in participants with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL) (TENACITY-01). Blood. https://doi.org/10.1182/blood-2025-5954